Pub. Date : 2020 Sep 15
PMID : 32942617
3 Functional Relationships(s)Download |
||||||
Sentence | Compound Name | Protein Name | Organism |
|||
| 1 | HSP90 Inhibitor, 17-DMAG, Alone and in Combination with Lapatinib Attenuates Acquired Lapatinib-Resistance in ER-positive, HER2-Overexpressing Breast Cancer Cell Line. | Lapatinib | estrogen receptor 1 | Homo sapiens | ||
| 2 | HSP90 Inhibitor, 17-DMAG, Alone and in Combination with Lapatinib Attenuates Acquired Lapatinib-Resistance in ER-positive, HER2-Overexpressing Breast Cancer Cell Line. | Lapatinib | estrogen receptor 1 | Homo sapiens | ||
| 3 | These results suggest that HSP90 inhibitors in patients with lapatinib-resistant Estrogen Receptor (ER) (+) HER2 (+) breast cancer are promising therapeutics for future clinical trials. | Lapatinib | estrogen receptor 1 | Homo sapiens | ||